Answers are grounded in this paper and cite their sources.
Thrombocytopaenia is a recognized complication after aortic valve replacement (AVR), sometimes it has been reported as heparin-induced, and it can be associated with high mortality and morbidity. This case report is describing the first case of thrombotic thrombocytopaenic purpura (TTP) after AVR using the Trifecta bioprosthesis.
No takes yet. Share an insight, caveat, or question.
Falconieri et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: